Elwyn Pharmacy Group is excited to announce the addition of Marc Stranz PharmD as Vice President of Compliance. Marc has worked for more than 30 years in sterile pharmacy compounding and was an early leader in the home infusion industry. He has held branch, regional, and corporate positions with several national providers, including Senior Vice President for Clinical and Strategic Operations at Coram and Vice President of Clinical Operations and Regulatory Affairs at BioScrip. He was also Corporate Director of Infusion Services for Omnicare and Chief Clinical Officer for BioScrip Specialty Services.
A recognized business leader and subject matter expert, his work is part of the core practice standards of the industry established by professional organizations and regulatory bodies as well as the body of policy and procedure used by home infusion organizations. Dr Stranz pioneered safe and efficient provision of advanced infusion therapies in home infusion and has sustained involvement in cutting-edge therapies. His expertise includes clinical and operational services, regulatory compliance, accreditation, sterile compounding, and design/build of cleanrooms and infusion facilities. He served on the USP Expert Panel for Sterile Compounding, the Board of Pharmaceutical Specialties Practice Analysis Taskforce in Sterile Compounding, and the Institute of Environmental Sciences and Technology (IEST) Working Group for Controlled Environments per USP Chapter 797.